Probing the ribosome-dependent mechanisms of human alphacoronavirus NSP1
Ended Project Grant Awarded Last action
- Award ID
- F31AI181514
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $102,444
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- New Haven, CT 06511, USA
Award details come from USAspending.gov.
Description
- Abstract
- The development of specific therapeutics infectious coronaviruses remains a significant challenge and requires a detailed mechanistic understanding of virus-host cell interactions and viral pathogenesis. A potential target for therapeutic intervention is the nonstructural protein 1 (NSP1), a major virulence factor produced by alpha- and beta-coronavirus (α-, β-COV) that regulates host gene expression. NSP1 is a key player in a strategy deemed "host shutoff," in which expression pathways are shifted from host to viral genes, allowing for virus proliferation and immune evasion. Biochemical and structural studies have shown that NSP1 exerts direct translational control, in certain cases binding to the 40S ribosomal subunit with nanomolar affinity. The structurally conserved n-terminal core of the protein is thought to be critical for its function, yet its contribution to NSP1's mechanisms remain unclear. Furthermore, α-COV NSP1S only contain and function solely through this core. Structural studies with NSP1 and the ribosome together have yet to resolve the NSP1 n-terminus, generating a GAP in knowledge regarding this domain and the protein's overall function, and impeding the development of effective drug candidates targeting NSP1. The goal of this proposal is to uncover structural insights into the NSP1 n-terminal core and establish NSP1's specificity in enacting host shut-off, focusing on NSP1 proteins in human alpha-coronaviruses. The study will contribute to the long-term goal of understanding coronavirus pathogenesis and evolution and developing effective therapies against the many prevalent diseases caused by coronaviruses.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $34,544 | |
| Amendment | $33,950 | |
| Amendment | $0 | |
| Original award | $33,950 |
Quick answers
Who received award F31AI181514?
F31AI181514 was awarded to Yale Univ by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 13, 2025.
How much is award F31AI181514 worth?
$102,444 has been obligated on F31AI181514.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award